“Dupilumab-Treated Patients With Prurigo Nodularis Experience Improvements in Itch and Skin Pain: 6-Month Results From the RELIEVE-PN Study” (2025) SKIN The Journal of Cutaneous Medicine, 9(6), p. s715. doi:10.25251/ayd9p145.